These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Molecular mechanisms of improvement of hydrolytic antibody 6D9 by site-directed mutagenesis. Takahashi-Ando N; Shimazaki K; Kakinuma H; Fujii I; Nishi Y J Biochem; 2006 Oct; 140(4):509-15. PubMed ID: 16921165 [TBL] [Abstract][Full Text] [Related]
23. A new visual screening assay for catalytic antibodies with retro-aldol retro-Michael activity. Shamis M; Barbas CF; Shabat D Bioorg Med Chem Lett; 2007 Mar; 17(5):1172-5. PubMed ID: 17234408 [TBL] [Abstract][Full Text] [Related]
24. Mutational and inhibitory analysis of a catalytic antibody. Implication for drug discovery. Phichith D; Bun S; Padiolleau-Lefèvre S; Banh S; Thomas D; Friboulet A; Avalle B Mol Immunol; 2009 Dec; 47(2-3):348-56. PubMed ID: 19828199 [TBL] [Abstract][Full Text] [Related]
25. Complete reaction cycle of a cocaine catalytic antibody at atomic resolution. Zhu X; Dickerson TJ; Rogers CJ; Kaufmann GF; Mee JM; McKenzie KM; Janda KD; Wilson IA Structure; 2006 Feb; 14(2):205-16. PubMed ID: 16472740 [TBL] [Abstract][Full Text] [Related]
26. Catalytic antibodies and their applications. Hanson CV; Nishiyama Y; Paul S Curr Opin Biotechnol; 2005 Dec; 16(6):631-6. PubMed ID: 16243512 [TBL] [Abstract][Full Text] [Related]
27. Theoretical study of catalytic efficiency of a Diels-Alderase catalytic antibody: an indirect effect produced during the maturation process. Martí S; Andrés J; Moliner V; Silla E; Tuñón I; Bertrán J Chemistry; 2008; 14(2):596-602. PubMed ID: 17960540 [TBL] [Abstract][Full Text] [Related]
28. Theory of proteolytic antibody occurrence. Paul S; Nishiyama Y; Planque S; Taguchi H Immunol Lett; 2006 Feb; 103(1):8-16. PubMed ID: 16290203 [TBL] [Abstract][Full Text] [Related]
29. Rational approach to polymer-supported catalysts: synergy between catalytic reaction mechanism and polymer design. Madhavan N; Jones CW; Weck M Acc Chem Res; 2008 Sep; 41(9):1153-65. PubMed ID: 18793027 [TBL] [Abstract][Full Text] [Related]
30. Human catalytic antibody Se-scFv-B3 with high glutathione peroxidase activity. Huo R; Wei J; Xu J; Lv S; Zheng Q; Yan F; Su J; Fan J; Li J; Duan Y; Yu Y; Jin F; Sun W; Shi Y; Cong D; Li W; Yan G; Luo G J Mol Recognit; 2008; 21(5):324-9. PubMed ID: 18574795 [TBL] [Abstract][Full Text] [Related]
31. Structure of a pseudomerohedrally twinned monoclinic crystal form of a pyridoxal phosphate-dependent catalytic antibody. Golinelli-Pimpaneau B Acta Crystallogr D Biol Crystallogr; 2005 Apr; 61(Pt 4):472-6. PubMed ID: 15805602 [TBL] [Abstract][Full Text] [Related]
34. Generation of humanized anti-DNA hydrolyzing catalytic antibodies by complementarity determining region grafting. Kim DS; Lee SH; Kim JS; Lee SC; Kwon MH; Kim YS Biochem Biophys Res Commun; 2009 Feb; 379(2):314-8. PubMed ID: 19103171 [TBL] [Abstract][Full Text] [Related]
35. Recent progress in asymmetric bifunctional catalysis using multimetallic systems. Shibasaki M; Kanai M; Matsunaga S; Kumagai N Acc Chem Res; 2009 Aug; 42(8):1117-27. PubMed ID: 19435320 [TBL] [Abstract][Full Text] [Related]